K. Balogh, E. Nemes, G. Uhercsák, Zs. Kahán, Gy. Lázár, Gy. Farkas, H. Polyánka, E. Kiss, R. Gyulai, E. Varga, E. Kereszt-Határvolgyi, L. Kaizer, L. Haracska, L. Tiszlavicz, L. Kemény, J. Oláh and M. Széll, “Melanoma-PreDisposing CDKN2A Mutations in Association with Breast Cancer: A Case-Study and a Meta-Analysis,” In: M. Murph, Ed., Melanoma in the Clinic—Diagnosis, Management and Complications of Malignancy, InTech, Rijeka, 2011, pp. 211-224.

has been cited by the following article:

• TITLE: Management of the Case of a Young Female Patient with Multiple Malignancies and Germline R24P CDKN2A Gene Mutation

  AUTHORS: Gabriella Uhercsák, Ágnes Dobi, Roland Gyulai, Judit Oláh, László Kaizer, Katalin Ormándi, Adrienne Cserháti, György Lázár, Gyula Farkas, Zsuzsanna Kahán

  KEYWORDS: Breast Cancer; Melanoma; Pancreatic Cancer; R24P CDKN2A Gene Mutation

  JOURNAL NAME: Journal of Cancer Therapy, Vol.4 No.7A, July 17, 2013

  ABSTRACT: The case of a young female patient with metachronous primary melanomas, advanced breast and pancreatic cancers is reported. The 5 different tumors diagnosed within six years, were managed with curative intent. Genetic analysis revealed the mutation of the R24P CDKN2A gene in a heterozygote form in both the patient and her father. Careful tertiary prevention during the follow-up of the patient is needed.